MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    An Algorithmic Approach to Assessing Cognitive Functioning in Individuals with REM Sleep Behavior Disorder

    G. Schneider, A. Avidan, D. Bliwise, S. Criswell, E. During, J. Elliott, L. Forsberg, J-F. Gagnon, M. Howell, D. Huddleston, A. Keil, J. Lee-Iannotti, M. Lim, J. Mcleland, M. Miglis, E. Mignot, R. Postuma, C. Schenck, D. Shprecher, E. ST. Louis, A. Videnovic, B. Boeve, Y-E. Ju, J. Fields (Rochester, USA)

    Objective: To apply an algorithmic approach to interpretation of cognitive data to assess cognitive impairment in RBD participants. Background: Cognitive changes in emerging neurodegenerative disease…
  • 2023 International Congress

    Association of Increased Frontal White Matter A2A Receptor Availability with Decreased Frontal Gray Matter Volume in Patients with Parkinson’s Disease

    I. Waggan, E. Rissanen, J. Tuisku, M. Matilainen, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)

    Objective: We sought to investigate in vivo changes in A2A receptor availability in cerebral white matter of PD patients and its association with gray matter…
  • 2023 International Congress

    How COVID-19 Impacted Patients with Wilson’s disease? A Questionnaire-based Study From An Indian Movement Disorder Clinic

    A K. Shrivastava, A. Aliyar, MR. Divya, F. Mustafa, K. Sai Krishna, R. Rajan, K. Soman Pillai ()

    Objective: To assess the impact of COVID-19 related disruption on patients with Wilson’s disease. Background: Health-care systems around the world were drastically impacted by the…
  • 2023 International Congress

    Alopecia in females with young onset Parkinson’s Disease: an exploratory survey

    K. Fisher, E. Clifford, N. Piniella, A. Leder, R. Gallagher (Glen Head, USA)

    Objective: To explore the symptoms of females with young onset Parkinson's Disease (YOPD), specifically alopecia, in comparison to females with traditional onset Parkinson’s Disease (TOPD).…
  • 2023 International Congress

    Development of a patient journey map for people living with Parkinson’s disease

    A. Albanese, R. Case, A. Amit, S. Ben-Hamo (Milan, Italy)

    Objective: Develop a Motor Fluctuations Patient Journey Map (MFPJM) for people with Parkinson’s disease (PwP) to describe the holistic experience from pre-diagnosis through long-term treatment,…
  • 2023 International Congress

    Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene

    C. Koros, I. Alefanti, AM. Simitsi, A. Bougea, N. Papagiannakis, R. Antonelou, C. Kartanou, M. Bozi, I. Pachi, S. Varvaresos, A. Zahou, E. Stanitsa, M. Kodounis, M. Maniati, M. Panas, G. Paraskevas, S. Papageorgiou, C. Potagas, G. Karadima, G. Koutsis, L. Stefanis (Athens, Greece)

    Objective: The aim of the present report was to evaluate the cognitive profile of symptomatic Parkinson’s disease (PD) patients in a p.A30G SNCA genetic cohort.…
  • 2023 International Congress

    Impact of the COVID-19 pandemic in the long-term efficacy of botulinum toxin treatment

    F. Barros, C. Nunes, F. Magalhães, A. Mestre, C. Machado, D. Carneiro (Coimbra, Portugal)

    Objective: To analyse the impact of the COVID-19 pandemic in the long-term efficacy of treatment with botulinum toxin (BoT). Background: The COVID-19 pandemic brought new…
  • 2023 International Congress

    Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

    S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)

    Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…
  • 2023 International Congress

    Obsessive-Compulsive symptoms in Parkinson’s Disease: beyond the Impulse Control Disorders

    D. Damas, M. Fernandes, I. Carvalho, C. Fernandes, A. Araújo, I. Cunha, J. Lemos, F. Moreira (Coimbra, Portugal)

    Objective: To characterize the obsessive-compulsive symptoms (OCS) and Impulse Control Disorders (ICD) in patients with Parkinson’s Disease (PD), as well as explore the correlation between…
  • 2023 International Congress

    Pain and sleep in Parkinson’s disease

    A. Zarnoveanu, S. Diaconu, B. Ciopleias, L. Ungureanu, T. Dragan, B. Ciocanescu, T. Moldovan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: Pain and sleep disturbances are among the most frequently encountered non-motor symptoms in Parkinson’s disease (PD). Background: The aim of this study was to…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley